Last reviewed · How we verify
Flurbiprofen and remifentanil — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Flurbiprofen and remifentanil (Flurbiprofen and remifentanil) — Changhai Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Flurbiprofen and remifentanil TARGET | Flurbiprofen and remifentanil | Changhai Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Flurbiprofen and remifentanil CI watch — RSS
- Flurbiprofen and remifentanil CI watch — Atom
- Flurbiprofen and remifentanil CI watch — JSON
- Flurbiprofen and remifentanil alone — RSS
Cite this brief
Drug Landscape (2026). Flurbiprofen and remifentanil — Competitive Intelligence Brief. https://druglandscape.com/ci/flurbiprofen-and-remifentanil. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab